Financials
Financial year 2025
MAXIPHARMA from Charleroi, company number BE0460509874, closed financial year 2025 with a result of € 89,731 after tax. For that financial year MAXIPHARMA recorded a gross margin of € 129,621 and equity of € 227,467. Compared with financial year 2024, the result moved from € -9,992 to € 89,731. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.
€ 227,467
▲ 65% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 89,731
▲ still € 9,992 loss in 2024
Profit after tax over the fiscal year.
€ 267,253
▲ 209% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 221,270.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,665
▼ 59% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 37,415
▲ € 35,204 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 12,526 | € 4,042 | € 1,212 | € 129,621 | ▲ € 128,409 |
| Profit after taxes | € 429 | € -8,390 | € -9,992 | € 89,731 | ▲ € 99,723 |
| Equity | € 183,268 | € 154,878 | € 137,736 | € 227,467 | ▲ 65% |
| Total debts | € 34,249 | € 36,614 | € 11,275 | € 41,744 | ▲ 270% |
| Cash | € 104,847 | € 95,623 | € 86,587 | € 267,253 | ▲ 209% |
| Land & buildings | € 49,193 | € 43,430 | € 37,856 | - | |
| Retained profit | € 177,070 | € 148,681 | € 131,539 | € 221,270 | ▲ 68% |
| Dividend | € 15,000 | € 20,000 | € 7,150 | € 0 | ▼ 100% |
| Bank debt | € 3,691 | € 1,231 | € 0 | € 0 | |
| Balance sheet total | € 217,516 | € 191,492 | € 149,012 | € 269,211 | ▲ 81% |
By gross margin, MAXIPHARMA ranks 4th of 6 companies with main activity “Detailhandel in farmaceutische producten” in Charleroi that publish figures (fiscal year 2025).
Key figures of MAXIPHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about MAXIPHARMA the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to MAXIPHARMA?
What happened at MAXIPHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 89,731. filed late Source: NBB ↗
- New establishment in Charleroi. KBO
- Start of the company according to the CBE. KBO
In short
From € 429 profit in 2022 to € 89,731 profit in 2025.
Paid € 37,224 in corporate taxes since 2022.
Best year ever: 2025, with € 89,731 profit.
Paid out € 42,150 in dividends to the owners in total.
Management
Behind MAXIPHARMA is MYRIAM BROSE.
Directors
According to the 2025 annual accounts
MYRIAM BROSE
Director
Establishments
Establishment units
Physical locations of this company
Rue de la Neuville 66 box 111
6000 Charleroi
Chaussée de Fleurus 25
6060 Charleroi
Active since 13 June 1997
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Charleroi
Same main activity (Detailhandel in farmaceutische producten), 5 active companies in Charleroi, largest first.
€ 701,722 gross margin · 2025
€ 548,499 gross margin · 2025
€ 324,670 gross margin · 2025
€ 103,029 gross margin · 2026
€ 14,454 gross margin · 2023
Details
- Company number
- 0460.509.874
- VAT number
- BE 0460.509.874
- Registered office
- Rue de la Neuville 66 bus 111, 6000 Charleroi
- Names & denominations
- MAXIPHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 21 April 1997
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers